Seeking Alpha

Nahodny Okoloiduci

Nahodny Okoloiduci
Send Message
View as an RSS Feed
View Nahodny Okoloiduci's Comments BY TICKER:
Latest  |  Highest rated
  • Chinese Fashion Company Vlov Inc. Sets Sights On U.S. Presence [View instapost]
    So they filed for deregistration of common stock yesterday. Shareholders are 80% off their investment overnight.
    Aug 8, 2013. 03:03 AM | Likes Like |Link to Comment
  • Whiting USA Shareholders Are Going To Lose Half Their Money - Again [View article]
    this stock will end at zero, plus $3 - $4 distributions
    Apr 26, 2013. 12:52 PM | Likes Like |Link to Comment
  • Whiting USA Trust I States That Its Policy Is Not to Comment on Unusual Market Activity [View article]
    Unusual market activity... yes, WHX is unusually overvalued.
    Apr 25, 2013. 03:39 PM | Likes Like |Link to Comment
  • Whiting USA Shareholders Are Going To Lose Half Their Money - Again [View article]
    PE of 2? This is royalty trust my friend, it will liquidate in less than 2 years with zero at the end. Like you are paying me 2 bucks for every dollar I'll give you back in the future. Good for me.
    Apr 25, 2013. 09:45 AM | 1 Like Like |Link to Comment
  • Apache: Finding Value In Today's Market [View article]
    The problem is that APA seems to be "a value" for long time now, yet the stock just don't deliver.
    Apr 18, 2013. 06:22 AM | 1 Like Like |Link to Comment
  • An ironic turn in the Central European Distribution (CEDC) bankruptcy saga: Roustam Tariko's Roust Trading which will control 100% of the restructured equity — announced today that it has informed the company of its intention to "make a $5M payment to all existing shareholders of CEDC" including (drumroll) Roust Trading.  [View news story]
    ...means 0.06 per share? oh what a deal
    Apr 9, 2013. 04:25 PM | Likes Like |Link to Comment
  • Short Armour And Long American Capital: mREIT Pair Trade [View article]
    Shorting ARR? Good luck with that.
    Apr 8, 2013. 03:33 AM | Likes Like |Link to Comment
  • Can Spectrum Pharmaceuticals Regain Investor Trust? [View article]
    Raj must go, that's for sure. Nobody will ever trust SPPI with him at the helm.
    But $10 sale would be far stupid move, though. That will not happen.
    Apr 5, 2013. 07:15 AM | Likes Like |Link to Comment
  • Can Spectrum Pharmaceuticals Regain Investor Trust? [View article]
    Cut their dividend? Divy going away?
    .
    There wasnt paid any regular dividend ever, my friend. Just a one-time special one...
    Apr 5, 2013. 03:12 AM | Likes Like |Link to Comment
  • Great Northern Iron Properties: Investors Are Playing Russian Roulette [View article]
    This will not go up since distributions value until liquidation of the trust ist about half of present market price. GNI is perfect example of so called dividend trap. I am surprised it did not fell to $40, but it will.
    Apr 4, 2013. 01:24 AM | Likes Like |Link to Comment
  • Arcam AB, A Very Promising 3D Printer Company [View article]
    You can trade it in Stockholm (Nasdaq OMX Exchange for example), with far more liquidity.
    Apr 3, 2013. 05:08 AM | 1 Like Like |Link to Comment
  • Can Spectrum Pharmaceuticals Regain Investor Trust? [View article]
    "Surprisingly there is still a large short interest"
    .
    Any source backing this statement?
    According to official SI reporting by Nasdaq, last known short interest was reported as of Mar 15 (settlement date), count T-3 and you have your SI number before the big drop.
    Apr 2, 2013. 08:29 AM | Likes Like |Link to Comment
  • North Atlantic Drilling Has It All: High Dividend, Growth Prospects, And A Catalyst [View article]
    "At the end of business on Friday 15 March 2013, Prosafe had approximately USD 550,000 on deposit in one bank in Cyprus."
    Mar 28, 2013. 02:09 AM | Likes Like |Link to Comment
  • Lone Pine Resources: Time Is On My Side [View article]
    Well, according to the co's latest fillings, LPR's net asset value is $9.81, so $3 is just a first step. Let's see if Fitzpatrick will be appointed as permanent CEO or it's about to sale whole company for some premium to NAV.
    I will add on monday since this is a bargain.
    Mar 16, 2013. 05:11 AM | 1 Like Like |Link to Comment
  • Spectrum Pharmaceuticals (SPPI) guides FY13 revenue below Street estimates, now anticipating total revenues in the range of $160M to $180M. Analysts were projecting FY13 revenue to come in at $297M. The company cites a change in ordering patterns of Fusilev and an increase in generic competition in its hospital segment for the shortfall, following the recent stabilization of the folate analog market. Shares remain halted AH. [View news story]
    SPPI have some catalysts ahead, Apaziqone, Belinostat, development of Renazorb and plenty other candidates... so even if weaker revenue will materialize, the big part of short thesis is already off.
    Mar 13, 2013. 09:37 AM | Likes Like |Link to Comment
COMMENTS STATS
147 Comments
134 Likes